Dry Eye Disease | DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

FDA extends Reproxalap review

March 26, 2026 Evan Vega

FDA Extends Review of Reproxalap for Dry Eye Disease to March 16 Amid Clinical Study Requests

The FDA extended its review of Aldeyra’s reproxalap for dry eye disease to March 16, 2026, after requesting a clinical study report.